(Q73117695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

A prospective economic evaluation of basiliximab (Simulect) therapy following renal transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

M I Lorber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Fastenau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Wilson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J DiCesare

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M L Hall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

published in

Clinical Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

479-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

Screening for basiliximab exposure-response relationships in renal allotransplantation

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140506.X

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140506.X

7 January 2021

A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140506.X

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140506.X

7 January 2021

Early versus late acute renal allograft rejection: impact on chronic rejection.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140506.X

7 January 2021

Cost-Effectiveness Studies of Renal Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140506.X

7 January 2021

10.1034/J.1399-0012.2000.140506.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11048993%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference